In this final installment of the "Breaking down diabetes" series, physician-researcher Randall Stafford weighs in on a debate about blood sugar levels that relates to drug prices.
The strange skeletal remains of a fetus discovered in Chile have turned up new insights into the genetics of some bone diseases, according to a new study.
Seventeen million Americans live with the aftermath of stroke, including difficulty communicating, moving around, and taking care of their most basic needs. Now, Stanford researchers are working to give those survivors new hope.
Stanford research shows that nearly one in 20 reproductive-age women have depression and less than one-third are taking antidepressants.
In this Breaking Down Diabetes installment, physician-research Randall Stafford clarifies the pros and cons of insulin use in Type 2 diabetes.
On the Future of Everything radio show, Stanford bioengineer Jennifer Cochran discusses her development of "tumor-targeting missiles" that deliver chemotherapy as "cargo" to more effectively kill cancer.
Clinicians now have up to 24 hours to treat a stroke, thanks in part to research and tools developed at Stanford Medicine.
A new mini-experiment from Stanford's WELL program challenges individuals to take five minutes out of their day to meditate, with the goal of improving well-being.
This Stars of Stanford Medicine Q&A features anesthesiologist and researcher Vivianne Tawfik, who examines the roots of chronic pain.
A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.
Researchers have identified an immune cell type with an apparently critical role in multiple sclerosis, and a way to block its entry into the brain.
A new technique gives doctors an early view of which pediatric leukemia patients will relapse, and may point the way toward better cancer drugs.
Scientists have used genome editing to pinpoint genes that reveal information about ALS and may even protect against the degeneration of neurons.
In this video, Stanford psychologist David Spiegel discusses how hypnosis reduces pain and could help curb the opioid crisis.
A group of researchers identified adverse and previously unknown drug reactions by sifting through millions of social health forum posts.
Researchers have found a way to turn off a key driver of inflammation in celiac disease, an autoimmune disease that affects millions of Americans.